Ifosfamide
Specifications
3778-73-2CAS Number
223-237-3EC Number
N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amineIUPAC Name
C7H15Cl2N2O2PChemical Formula
261.08 g/molMolecular Weight
ifosfamide; 3778-73-2; Isophosphamide; Iphosphamide; Isofosfamide; Ifex; Ifosfamid; Isoendoxan; Iphosphamid; Holoxan; Mitoxana; Naxamide; Cyfos; I-Phosphamide; Ifsofamide; ASTA Z 4942; Ifosfamida; Ifosfamidum; MJF 9325; MJF-9325; ifomide; isosfamide; NSC-109724; Z4942; A 4942; Z-4942; 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide; DTXSID7020760; NSC 109724; Z 4942; ISOCYCLOPHOSPHAMIDE; N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide; 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide; UM20QQM95Y; NSC109724; N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide; DTXCID90760; N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide; 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide; CHEBI:5864; Iso-Endoxan; N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine; 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide; Iso Endoxan; 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2lambda5-oxazaphosphinan-2-one; Asta Z-4942; Holoxane; Ifomida; Seromida; Tronoxal; Ifolem; Ifoxan; 3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2$l^(5)-oxazaphosphinan-2-one; 3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2lambda5-oxazaphosphinan-2-one; 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2$l^{5}-oxazaphosphinan-2-one; IFO-Cell; NSC109,724; NSC 109,724; RefChem:57655; L01AA06; 2-oxo-N,3-bis-(2-chloroethyl) tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine; 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide; 223-237-3; Holoxan 1000; NCI-C01638; MFCD00057374; 3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide; 3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxaazaphosphorin 2-oxide; N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide; Ifosphamide; 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide; 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide; 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide; N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide; NCGC00016639-01; CAS-3778-73-2; Ifosfamide Sterile; Ifosfamidum [INN-Latin]; Ifosfamida [INN-Spanish]; dexifosfamide; N,3-bis(2-chloroethyl)-2-oxo-1,3,2|E5-oxazaphosphinan-2-amine; (2-CHLORO-ETHYL)-[(R)-3-(2-CHLORO-ETHYL)-2-OXO-2LAMBDA5-[1,3,2]OXAZAPHOSPHINAN-2-YL]-AMINE; CCRIS 352; HSDB 7023; SR-05000002022; EINECS 223-237-3; IFEX (TN); UNII-UM20QQM95Y; BRN 0611835; Ifosfamide (JAN/USP/INN); Ifosfamid A; Ifosfamide CRS; 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorineoxide; Ifosfamide; (RS)-N,3-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide; Ifosfamide in bulk; 2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd; N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide; N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]; Ifosfamide [USAN:USP:INN:BAN:JAN]; Ifosfamide (Standard); starbld0001221; Ifosfamide, >=98%; IFOSFAMIDE [MI]; IFOSFAMIDE [INN]; IFOSFAMIDE [JAN]; Prestwick0_000833; Prestwick1_000833; Prestwick2_000833; Prestwick3_000833; IFOSFAMIDE [HSDB]; IFOSFAMIDE [USAN]; IFOSFAMIDE [VANDF]; N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid; IFOSFAMIDE [MART.]; SCHEMBL4885; CHEMBL1024; IFOSFAMIDE [USP-RS]; IFOSFAMIDE [WHO-DD]; BSPBio_000785; ISOPHOSPHAMIDE [IARC]; MLS002154021; Ifex (TN) (Bristol Meyers); SPBio_002706; BPBio1_000865; GTPL7201; Ifosfamide - Bio-X trade mark; orb1225156; orb1309923; orb1702010; orb3025460; SCHEMBL7036360; IFOSFAMIDE [EP IMPURITY]; IFOSFAMIDE [ORANGE BOOK]; IFOSFAMIDE [EP MONOGRAPH]; BDBM189358; GLXC-06009; HMS1570H07; HMS2090M12; HMS2093N07; HMS2097H07; HMS2232O10; HMS3374B08; HMS3654B15; HMS3714H07; HMS5079D09; IFOSFAMIDE [USP MONOGRAPH]; Pharmakon1600-01505480; {3-(2-Chloroethyl)-2-[(2-; WLN: T6NPOTJ AM2G BO B2G; Tox21_110539; Tox21_201815; Tox21_302775; BBL028071; EBC-11112; HY-17419R; MSK164343; N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine; NSC759154; s1302; STL058690; AKOS005711213; Tox21_110539_1; AB02316; AC-2113; CCG-213464; CS-1424; DB01181; FB24538; NSC-759154; Triphenylphosphineimine hemisulfate salt; N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine; NCGC00179435-01; NCGC00179435-02; NCGC00179435-03; NCGC00179435-06; NCGC00179435-07; NCGC00179435-10; NCGC00179435-15; NCGC00256413-01; NCGC00259364-01; AS-10978; BI166243; HY-17419; NCI60_000233; SMR001233348; SY066721; SBI-0206804.P001; DB-049196; AB00513932; I0713; I2056; NS00000356; SW197177-4; C07047; D00343; T25723; AB00513932-06; AB00513932-07; AB00513932-08; AB00513932_09; AB00513932_10; EN300-7476797; F862445; Q418560; SR-05000002022-1; SR-05000002022-3; SR-05000002022-5; BRD-A67097164-001-11-2; BRD-A67097164-001-17-9; BRD-A67097164-001-18-7; Ifosfamide, British Pharmacopoeia (BP) Reference Standard; Ifosfamide, European Pharmacopoeia (EP) Reference Standard; Ifosfamide, United States Pharmacopeia (USP) Reference Standard; 2,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy-; 2,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd; (RS)-N,3-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide; N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l;{5}-oxazaphosphinan-2-amine; {3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,} 2-oxazaphosphorine oxide; 1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide; 2H-1,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide; 2H-1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide; 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2lambda~5~-oxazaphosphinan-2-one; 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorine oxide; 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorineoxide; 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,2-oxazaphosphorine 2-oxide; N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphinan-2-amine 2-oxide #Synonyms
Products Containing Ifosfamide
홀록산주1000밀리그람(이포스파마이드)TRONOXAL 1.000 MG POLVO PARA SOLUCIÓN PARA PERFUSIÓNHOLOXAN 2000 mg, poudre pour usage parentéralHOLOXAN 1000 mg, poudre pour solution injectableIfosfamid bidiphar 1gIfoslibIfosfamide 1000 StadaIfosfamide 1000 StadaIfosfamide 1000 StadaHoloxanIfosfamideIfosfamide
Page 1 of 2
Companies Selling Ifosfamide
부광
부광약품(주)Republic of KoreaHH
HANGZHOU HONGQIN PHARMTECH CO.,LTDChinaYX
YANTAI XIANHUA TECHNOLOGY GROUP CO.,LTDChinaJH
Jiangsu Hengrui Pharmaceutical Co., Ltd.ChinaBS
Baxter S.L.SpainBA
BaxterUnited StatesBH
Baxter Healthcare (Asia) Pte LtdSingapore